68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression

被引:7
|
作者
Li, Chongjiao [1 ]
Chen, Qiongrong [2 ]
Tian, Yueli [1 ]
Chen, Jie [1 ]
Xu, Kui [1 ]
Xiao, Zhiwei [1 ]
Zhong, Juan [1 ]
Wu, Jianyuan [3 ]
Wen, Bing [1 ]
He, Yong [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Nucl Med, Wuhan, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Peoples R China
[3] Wuhan Univ, Clin Trial Ctr, Zhongnan Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
non-small cell lung cancer; lymph node metastasis; FAP expression; (68) Ga-FAPI; PET/CT; FDG PET/CT; F-18-FDG PET/CT;
D O I
10.2967/jnumed.123.266806
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fibroblast activation protein (FAP) is a promising diagnostic and therapeutic target in various solid tumors. This study aimed to assess the diagnostic efficiency of Ga-68-labeled FAP inhibitor (FAPI)-04 PET/CT for detecting lymph node metastasis in non-small cell lung cancer (NSCLC) and to investigate the correlation between tumor Ga-68-FAPI-04 uptake and FAP expression. Methods: We retrospectively enrolled 136 participants with suspected or biopsy-confirmed NSCLC who underwent Ga-68-FAPI-04 PET/CT for initial staging. The diagnostic performance of Ga-68-FAPI-04 for the detection of NSCLC was evaluated. The final histopathology or typical imaging features were used as the reference standard. The SUVmax and SUVmean, Ga-68-FAPI-avid tumor volume (FTV), and total lesion FAP expression (TLF) were measured and calculated. FAP immunostaining of tissue specimens was performed. The correlation between Ga-68-FAPI-04 uptake and FAP expression was assessed using the Spearman correlation coefficient. Results: Ninety-one participants (median age, 65 y [interquartile range, 58-70 y]; 69 men) with NSCLC were finally analyzed. In lesion-based analysis, the diagnostic sensitivity and positive predictive value of Ga-68-FAPI-04 PET/CT for detection of the primary tumor were 96.70% (88/91) and 100% (88/88), respectively. In station-based analysis, the diagnostic sensitivity, specificity, and accuracy for the detection of lymph node metastasis were 72.00% (18/25), 93.10% (108/116), and 89.36% (126/141), respectively. Tumor Ga-68-FAPI-04 uptake (SUVmax, SUVmean, FTV, and TLF) correlated positively with FAP expression (r = 0.470, 0.477, 0.582, and 0.608, respectively; all P <= 0.001). The volume parameters FTV and TLF correlated strongly with FAP expression in 31 surgical specimens (r = 0.700 and 0.770, respectively; both P < 0.001). Conclusion: Ga-68-FAPI-04 PET/CT had excellent diagnostic efficiency for detecting lymph node metastasis, and Ga-68-FAPI-04 uptake showed a close association with FAP expression in participants with NSCLC.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 50 条
  • [1] Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer
    Can, Canan
    Kepenek, Ferat
    Komek, Halil
    Gundogan, Cihan
    Kaplan, Ihsan
    Tasdemir, Bekir
    Guzel, Yunus
    Aguloglu, Nursin
    Karaoglan, Huseyin
    NUCLEAR MEDICINE COMMUNICATIONS, 2022, 43 (10) : 1084 - 1091
  • [2] In Vivo Fibroblast Activation of Systemic Sarcoidosis: A 68Ga-FAPI-04 PET/CT Imaging Study
    Wang, Jingnan
    Huo, Li
    Lin, Lu
    Niu, Na
    Li, Xiang
    DIAGNOSTICS, 2023, 13 (08)
  • [3] 68GA-FAPI PET/CT in the evaluation of Non-Small Cell Lung Cancer (NSCLC)
    Hirmas, N.
    Schuler, M.
    Darwiche, K.
    Eberhardt, W. E. E.
    Aigner, C.
    Stuschke, M.
    Kessler, L.
    Pabst, K. M.
    Barbato, F.
    Rischpler, C.
    Hautzel, H.
    Herrmann, K.
    Fendler, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S107 - S107
  • [4] 68Ga-FAPI-04 PET/CT in Assessment of Fibroblast Activation in Keloids: A Prospective Pilot Study
    Wang, Jiarou
    Yu, Nanze
    Wang, Guochang
    Wang, Rongxi
    Li, Linlin
    Jiang, Yuanyuan
    Sui, Huimin
    Sun, Yixin
    Li, Zhijin
    Long, Xiao
    Zhu, Zhaohui
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 16 - 22
  • [5] 68Ga-FAPI-04 PET/CT in a Small Sarcomatoid Renal Cell Carcinoma With Widespread Metastases
    Dong, Aisheng
    Yang, Bo
    Bai, Yushu
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (05) : 457 - 459
  • [6] 68Ga-FAPI-04 PET/CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-related interstitial lung disease
    Schmidkonz, C.
    Distler, J.
    Treutlein, C.
    Atzinger, A.
    Prante, O.
    Ritt, P.
    Goetz, T.
    Baeuerle, T.
    Cordes, M.
    Koehner, M.
    Kuwert, T.
    Ramming, A.
    Schett, G.
    Bergmann, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S158 - S159
  • [7] 68Ga-FAPI-04 PET/CT in Solitary Choroid Plexus Metastasis From Renal Cell Carcinoma
    Yang, Jian
    Dong, Aisheng
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : 885 - 887
  • [8] 68GA-FAPI-04 PET/CT STUDY EXTENSION FOR THE ASSESSMENT OF FIBROBLAST ACTIVATION AND RISK EVALUATION IN SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE
    Bergmann, C.
    Distler, J. H. W.
    Treutlein, C.
    Tascilar, K.
    Mueller, A. T.
    Atzinger, A.
    Matei, A. E.
    Knitza, J.
    Gyorfi, A. H.
    Lueck, A.
    Dees, C.
    Soare, A.
    Ramming, A.
    Schonau, V.
    Distler, O.
    Prante, O.
    Ritt, P.
    Goetz, I.
    Koehner, M.
    Cordes, M.
    Baeuerle, T.
    Kuwert, T.
    Schett, G.
    Schmidkonz, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 165 - 166
  • [9] Fibroblast Activation in Psoriasis Patients Assessed by 68Ga-FAPI-04 PET-CT Is Associated with Progression to Psoriatic Arthritis
    Fagni, Filippo
    Simon, David
    Kleyer, Arnd
    Tascilar, Koray
    Taubmann, Jule
    Bayat, Sara
    Minopoulou, Ioanna
    Mutlu, Melek Yalcin
    Atzinger, Armin
    Kuwert, Torsten
    Schett, Georg
    Schmidkonz, Chrstian
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2425 - 2427
  • [10] 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer
    Civan, Caner
    Isik, Emine Goknur
    Karadogan, Seyfullah
    Sanli, Yasemin
    Kuyumcu, Serkan
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (05) : E223 - E224